Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.09 USD
Change Today +0.23 / 5.96%
Volume 44.1K
EVAR On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

lombard medical inc (EVAR) Snapshot

Open
$3.85
Previous Close
$3.86
Day High
$4.10
Day Low
$3.82
52 Week High
09/18/14 - $7.78
52 Week Low
07/27/15 - $3.26
Market Cap
66.2M
Average Volume 10 Days
29.7K
EPS TTM
$-2.13
Shares Outstanding
16.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LOMBARD MEDICAL INC (EVAR)

Related News

No related news articles were found.

lombard medical inc (EVAR) Related Businessweek News

No Related Businessweek News Found

lombard medical inc (EVAR) Details

Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company’s principal product is Aorfix, which is an endovascular stent-graft for the treatment of an abdominal aortic aneurysm with angulation at the neck of the aneurysm of up to 90 degrees. It is also developing stent-graft system to treat thoracic aortic aneurysms. Lombard Medical, Inc. sells its products directly through its direct sales force and third-party distributors. The company was founded in 2000 and is headquartered in Irvine, California.

192 Employees
Last Reported Date: 04/30/15
Founded in 2000

lombard medical inc (EVAR) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $592.9K
Chief Financial Officer
Total Annual Compensation: $19.4K
President of North America
Total Annual Compensation: $313.1K
Vice President of Global Clinical & Regulator...
Total Annual Compensation: $265.8K
Vice President of Global Innovation and Devel...
Total Annual Compensation: $85.9K
Compensation as of Fiscal Year 2014.

lombard medical inc (EVAR) Key Developments

Altura Medical, Inc., Lombard Medical, Inc. - M&A Call

To consider the acquisition of Altura Medical

Lombard Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Reaffirms Revenue Guidance for the Year 2015

Lombard Medical, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company's revenue was $4.5 million compared with $2.2 million a year ago. Operating loss was $8.2 million compared with $11.4 million a year ago. Loss before taxation was $8.4 million compared with $11.3 million a year ago. Loss for the period was $8.2 million compared with $11.1 million a year ago. Basic and diluted loss per ordinary share from continuing operations was 50.6 cents compared with 75.9 cents a year ago. For the six months, the company's revenue was $7.9 million compared with $4.3 million a year ago. Operating loss was $17.99 million compared with $18.5 million a year ago. Loss before taxation was $18.2 million compared with $18.4 million a year ago. Loss for the period was $17.7 million compared with $17.99 million a year ago. Basic and diluted loss per ordinary share from continuing operations was 109.6 cents compared with 149.1 cents a year ago. Net cash outflow from operating activities was $14.8 million compared with $16.5 million a year ago. Purchase of property, plant and equipment was $0.83 million compared with $1.2 million a year ago. Purchase of intangible assets was $0.02 million compared with $0.25 million a year ago. The company reaffirms that it expects to achieve revenue for 2015 of between $18 million and $20 million. This growth is expected to result from a more than doubling of the combined number of Aorfix procedures for the company's four large markets (U.S., Japan, UK and Germany) and pricing that remains stable in those markets.

Lombard Medical, Inc., Q2 2015 Earnings Call, Jul 27, 2015

Lombard Medical, Inc., Q2 2015 Earnings Call, Jul 27, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVAR:US $4.09 USD +0.23

EVAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $27.79 USD +1.20
CryoLife Inc $10.95 USD -0.06
LeMaitre Vascular Inc $14.24 USD +0.84
TriVascular Technologies Inc $6.36 USD -0.09
Vascular Solutions Inc $37.23 USD +0.03
View Industry Companies
 

Industry Analysis

EVAR

Industry Average

Valuation EVAR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.7x
Price/Book 1.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LOMBARD MEDICAL INC, please visit www.lombardmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.